ClinicalTrials.govpublic full text
Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)
hepatocellular carcinoma, advance, hepatocellular carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 855582
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.